Skip to content
Inciteful Med

Neurodevelopment and Psychiatric Risks

Published: | Updated:

Individuals with 22q11.2 deletion syndrome face increased risks for psychiatric conditions, including ADHD, autism, anxiety, and a 25% risk of developing schizophrenia in adulthood. Proactive psychiatric care and early intervention significantly improve long-term mental health outcomes.

Key Takeaways

  • • Most individuals with 22q11.2 deletion syndrome require an Individualized Education Program (IEP) to support challenges with abstract concepts and executive function.
  • • Behavioral health conditions are common, with high rates of anxiety, ADHD, and autism spectrum disorder.
  • • There is a significant genetic vulnerability for psychiatric disorders, with about 25% developing a schizophrenia-spectrum disorder in early adulthood.
  • • Establishing a relationship with a psychiatrist early and monitoring for red flags like social withdrawal or paranoia are critical proactive steps.
  • • Early intervention with appropriate medications drastically improves long-term outcomes for those who develop psychotic symptoms.

The 22q11.2 deletion affects more than just physical health; it also impacts how the brain develops and processes information. Understanding these risks early allows individuals and families to put “safety nets” in place that can significantly improve quality of life [1][2].

Learning and the “22q Cognitive Profile”

Most individuals with 22q11.2DS experience some level of learning challenge. While IQ scores vary widely, the average often falls in the “borderline” to “below average” range [3][4].

  • Strengths and Challenges: There is often a relative strength in rote memorization and reading decoding, but abstract concepts, complex math, and “executive functions” (like planning and organization) can be difficult [5][6].
  • Educational Support: The vast majority of children benefit from an Individualized Education Program (IEP) or specialized classroom support tailored to their unique learning style [2][7].

Behavioral Health

  • ADHD: Approximately 30–40% of children and adults with 22q11.2DS meet the criteria for Attention-Deficit/Hyperactivity Disorder (ADHD), often the “inattentive” type [8][9].
  • Anxiety: Anxiety is one of the most frequent challenges, appearing in up to 50% of individuals. This can range from separation anxiety to social phobia [8][10].
  • Autism Spectrum Disorder (ASD): Features of autism, such as challenges with social communication, are seen in about 20–40% of individuals [8][11].

Adolescent and Adult Mental Health

One of the most concerning aspects of 22q11.2DS is the increased risk for psychiatric disorders in early adulthood. It is helpful to view this risk as a “genetic vulnerability” that requires proactive monitoring, rather than an inevitability or a doom sentence [12][13].

  • Schizophrenia and Psychosis: Research shows that about 25% (1 in 4) of individuals with 22q11.2DS may develop a schizophrenia-spectrum disorder in late adolescence or early adulthood [12][14].
  • Mood Disorders: Adults are also at higher risk for depression and other mood disorders [15][16].

What You Can Do:
While these statistics can be frightening, there are highly effective, actionable steps to manage this risk:

  1. Monitor for Early Signs: Watch for “red flags” like severe social withdrawal, sudden unexplained drops in grades or work performance, paranoia, unusual thoughts, or extreme changes in sleep [6].
  2. Establish Proactive Care: Do not wait for a crisis. Establish a relationship with a psychiatrist early (by early adolescence) who understands 22q11.2DS [17].
  3. Early Intervention: If psychotic symptoms do emerge, early intervention with anti-psychotic medications (and avoiding recreational drugs) drastically improves long-term outcomes [18][19]. With proper treatment, many individuals manage their symptoms successfully and live fulfilling, independent lives [20].

Frequently Asked Questions

What is the cognitive profile of someone with 22q11.2 deletion syndrome?
Most individuals with 22q11.2 deletion syndrome experience some learning challenges, with average IQ scores falling in the borderline to below-average range. They often have strengths in rote memorization and reading, but struggle with abstract concepts, math, and planning.
Does 22q11.2 deletion syndrome cause autism or ADHD?
Yes, there is a higher risk for both conditions. About 30-40% of children and adults with the deletion meet the criteria for ADHD, and 20-40% show features of autism spectrum disorder, such as challenges with social communication.
What is the risk of schizophrenia with 22q11.2 deletion syndrome?
Research indicates that approximately 25% (or 1 in 4) of individuals with 22q11.2 deletion syndrome may develop a schizophrenia-spectrum disorder in late adolescence or early adulthood. Because of this genetic vulnerability, proactive monitoring by a psychiatrist is highly recommended.
What early warning signs of psychosis should I watch for?
Important red flags include severe social withdrawal, sudden unexplained drops in school or work performance, paranoia, unusual thoughts, and extreme changes in sleep patterns. If you notice these signs, contact a psychiatrist immediately.
How can schools support a child with 22q11.2 deletion syndrome?
Because of their unique learning profile, the vast majority of children with 22q11.2 deletion syndrome benefit from an Individualized Education Program (IEP) or specialized classroom support tailored to their specific needs.

Questions for Your Doctor

  • • When is the appropriate time to conduct a baseline neuropsychological evaluation, and how often should it be updated?
  • • Can you help me communicate my (or my child's) specific cognitive profile and learning needs to the school's IEP team or a workplace coordinator?
  • • What specific early warning signs of anxiety or psychosis should I be monitoring for during the teenage and early adult years?
  • • Are there psychiatrists in our network who have direct experience managing patients with 22q11.2 Deletion Syndrome?

Questions for You

  • • What are my (or my child's) greatest cognitive and social strengths, and how can we build upon them?
  • • How do I typically handle high-stress situations or major life transitions, and do I have adequate support?
  • • Am I ignoring any subtle changes in mood, social withdrawal, or sleep patterns that I should report to a doctor?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    22q11.2 deletion - a tiny piece leading to a big picture.

    McDonald-McGinn DM

    Nature reviews. Disease primers 2020; (6(1)):33 doi:10.1038/s41572-020-0169-x.

    PMID: 32327654
  2. 2

    Healthcare Transition to Adulthood in Patients with 22q11.2 Deletion Syndrome: A Comprehensive Literature Review and Transition Framework.

    MacIsaac MF, Mattia A, Montes LA, et al.

    The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2025; 10556656251331392 doi:10.1177/10556656251331392.

    PMID: 40223294
  3. 3

    Variability in Neuropsychological Phenotypes in Patients with 22Q11.2 Deletion Syndrome: Case Series.

    Wierzchowski A, Sablich-Duley S, Bordes Edgar V

    Developmental neuropsychology 2021; (46(5)):381-392 doi:10.1080/87565641.2021.1956498.

    PMID: 34311629
  4. 4

    The importance of understanding cognitive trajectories: the case of 22q11.2 deletion syndrome.

    Swillen A

    Current opinion in psychiatry 2016; (29(2)):133-7 doi:10.1097/YCO.0000000000000231.

    PMID: 26779858
  5. 5

    The emergence of psychotic experiences in the early adolescence of 22q11.2 Deletion Syndrome.

    Chawner SJRA, Niarchou M, Doherty JL, et al.

    Journal of psychiatric research 2019; (109()):10-17 doi:10.1016/j.jpsychires.2018.11.002.

    PMID: 30458299
  6. 6

    Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.

    Antshel KM, Fremont W, Ramanathan S, Kates WR

    Schizophrenia bulletin 2017; (43(4)):833-842 doi:10.1093/schbul/sbw135.

    PMID: 27798222
  7. 7

    Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.

    Mosheva M, Pouillard V, Fishman Y, et al.

    European child & adolescent psychiatry 2019; (28(1)):31-42 doi:10.1007/s00787-018-1184-2.

    PMID: 29934817
  8. 8

    Longitudinal Psychiatric and Developmental Outcomes in 22q11.2 Deletion Syndrome: A Systematic Review.

    Jhawar N, Brown MJ, Cutler-Landsman D, et al.

    Journal of developmental and behavioral pediatrics : JDBP 2021; (42(5)):415-427 doi:10.1097/DBP.0000000000000927.

    PMID: 34110308
  9. 9

    Neuroimaging Phenotypes Associated With Risk and Resilience for Psychosis and Autism Spectrum Disorders in 22q11.2 Microdeletion Syndrome.

    Jalbrzikowski M

    Biological psychiatry. Cognitive neuroscience and neuroimaging 2021; (6(2)):211-224 doi:10.1016/j.bpsc.2020.08.015.

    PMID: 33218931
  10. 10

    Time-based prospective memory in children and adolescents with 22q11.2 deletion syndrome.

    Souchay C, Dubourg L, Ballhausen N, et al.

    The Clinical neuropsychologist 2018; (32(5)):981-992 doi:10.1080/13854046.2017.1403652.

    PMID: 29132265
  11. 11

    Neuropsychological and ASD phenotypes in rare genetic syndromes: A critical review of the literature.

    Bush L, Scott MN

    The Clinical neuropsychologist 2022; (36(5)):993-1027 doi:10.1080/13854046.2021.1980111.

    PMID: 34569897
  12. 12

    Schizophrenia Spectrum Disorders in a Danish 22q11.2 Deletion Syndrome Cohort Compared to the Total Danish Population--A Nationwide Register Study.

    Vangkilde A, Olsen L, Hoeffding LK, et al.

    Schizophrenia bulletin 2016; (42(3)):824-31 doi:10.1093/schbul/sbv195.

    PMID: 26738530
  13. 13

    Association between prematurity and the evolution of psychotic disorders in 22q11.2 deletion syndrome.

    Midbari Kufert Y, Nachmani A, Nativ E, et al.

    Journal of neural transmission (Vienna, Austria : 1996) 2016; (123(12)):1491-1497 doi:10.1007/s00702-016-1607-5.

    PMID: 27517838
  14. 14

    A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.

    Gur RE, Bassett AS, McDonald-McGinn DM, et al.

    Molecular psychiatry 2017; (22(12)):1664-1672 doi:10.1038/mp.2017.161.

    PMID: 28761081
  15. 15

    Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study.

    Hoeffding LK, Trabjerg BB, Olsen L, et al.

    JAMA psychiatry 2017; (74(3)):282-290 doi:10.1001/jamapsychiatry.2016.3939.

    PMID: 28114601
  16. 16

    DiGeorge syndrome : Relevance of psychiatric symptoms in undiagnosed adult patients.

    Kraus C, Vanicek T, Weidenauer A, et al.

    Wiener klinische Wochenschrift 2018; (130(7-8)):283-287 doi:10.1007/s00508-018-1335-y.

    PMID: 29671046
  17. 17

    Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study.

    Fiksinski AM, Breetvelt EJ, Duijff SN, et al.

    Schizophrenia research 2017; (188()):59-62 doi:10.1016/j.schres.2017.01.032.

    PMID: 28119035
  18. 18

    The effectiveness and tolerability of pharmacotherapy for psychosis in 22q11.2 Deletion Syndrome: A systematic review.

    Tanham M, Chen R, Warren N, et al.

    The Australian and New Zealand journal of psychiatry 2024; (58(5)):393-403 doi:10.1177/00048674241233118.

    PMID: 38383990
  19. 19

    Efficacy of Low-Dose Aripiprazole for Treatment of Psychotic Symptoms in a Patient with 22q11.2 Deletion Syndrome.

    Kontoangelos K, Lazaratou E, Economou M, et al.

    Psychopharmacology bulletin 2020; (50(1)):35-39 doi:10.64719/pb.4600.

    PMID: 32214520
  20. 20

    Neurocognitive Functioning in Patients with 22q11.2 Deletion Syndrome: A Meta-Analytic Review.

    Moberg PJ, Richman MJ, Roalf DR, et al.

    Behavior genetics 2018; (48(4)):259-270 doi:10.1007/s10519-018-9903-5.

    PMID: 29922984

This page provides educational information about the cognitive and psychiatric risks associated with 22q11.2 deletion syndrome. It does not replace professional medical or psychiatric advice. Always consult your care team for evaluations and treatment.

Stay up to date

Get notified when new research about 22q11.2 deletion syndrome is published.

No spam. Unsubscribe anytime.